REGISTERED NUMBER: 06725408 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 OCTOBER 2024

FOR

MEDICINE AND SONS LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

R Daniels

G R Towlerton

REGISTERED OFFICE:

C/O Thompson Taraz Rand

Suite 20, New Cambridge House

Bassingbourn Road

Litlington

Cambridgeshire

SG8 0SS

BUSINESS ADDRESS:

10 Jesus Lane

Cambridge

Cambridgeshire

CB5 8BA

REGISTERED NUMBER:

06725408 (England and Wales)

ACCOUNTANTS:

Thompson Taraz Rand Ltd

Chartered Accountants

10 Jesus Lane

Cambridge

Cambridgeshire

CB5 8BA

FIXED ASSETS

Intangible assets

5

-

-

Tangible assets

6

23,093

30,792

Investments

7

-

-

23,093

30,792

CURRENT ASSETS

Debtors

8

619,959

571,617

Cash and cash equivalents

95,212

65,528

715,171

637,145

CREDITORS

Amounts falling due within one year

9

(29,358

)

(33,038

)

NET CURRENT ASSETS

685,813

604,107

TOTAL ASSETS LESS CURRENT LIABILITIES

708,906

634,899

PROVISIONS FOR LIABILITIES

10

(3,994

)

-

NET ASSETS

704,912

634,899

CAPITAL AND RESERVES

Called up share capital

11

2

2

Retained earnings

704,910

634,897

SHAREHOLDERS' FUNDS

704,912

634,899

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 October 2025 and were signed on its behalf by:

G R Towlerton - Director

1.	STATUTORY INFORMATION

Medicine and Sons Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3.	ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover is derived from general medical practice activities and measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery

-

25% on cost, 25% on reducing balance and 20% on cost

Financial instruments

Basic financial assets and basic financial liabilities as defined under section 11 of FRS 102, including trade and other debtors, trade and other creditors, cash and bank balances and investments in commercial paper, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

5.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 November 2023

and 31 October 2024

252,000

AMORTISATION

At 1 November 2023

and 31 October 2024

252,000

NET BOOK VALUE

At 31 October 2024

-

At 31 October 2023

-

6.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 November 2023

and 31 October 2024

72,882

DEPRECIATION

At 1 November 2023

42,090

Charge for year

7,699

At 31 October 2024

49,789

NET BOOK VALUE

At 31 October 2024

23,093

At 31 October 2023

30,792

7.	FIXED ASSET INVESTMENTS

Other

investments

£

COST

At 1 November 2023

and 31 October 2024

60,000

PROVISIONS

At 1 November 2023

and 31 October 2024

60,000

NET BOOK VALUE

At 31 October 2024

-

At 31 October 2023

-

8.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

£

Trade debtors

8,900

10,323

Other debtors

611,059

561,294

619,959

571,617

9.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

£

Taxation and social security

23,175

15,845

Other creditors

6,183

17,193

29,358

33,038

10.	PROVISIONS FOR LIABILITIES

2024

2023

£

£

Deferred tax

3,994

-

Deferred

tax

£

Provided during year

3,994

Balance at 31 October 2024

3,994

11.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2024

2023

value:

£

£

2

Ordinary

£1

2

2

12.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 October 2024 and 31 October 2023:

2024

2023

£

£

R Daniels

Balance outstanding at start of year

(2,814

)

(1

)

Amounts advanced

49,909

-

Amounts repaid

(11,482

)

(2,813

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

35,613

(2,814

)

G R Towlerton

Balance outstanding at start of year

-

-

Amounts advanced

49,909

-

Amounts repaid

(14,296

)

-

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

35,613

-

13.	RELATED PARTY DISCLOSURES

At the balance sheet date an amount of £539,834 (2023: £561,294) was due from a related company and is disclosed within other debtors.